UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Re: Detection of Individual Prostate Cancer Foci via Multiparametric Magnetic Resonance Imaging

European urology, 2019-11, Vol.76 (5), p.704-705

2019

Volltextzugriff (PDF)

Radical inguinal orchidectomy: the gold standard for initial management of testicular cancer

Translational andrology and urology, 2020-12, Vol.9 (6), p.3094-3102

2020

Volltextzugriff (PDF)

Effects of granulocyte-macrophage colony-stimulating factor and dose intensification of V-ICE chemotherapy in small-cell lung cancer: a prospective randomized study of 300 patients

Journal of clinical oncology, 1998-02, Vol.16 (2), p.642-650

1998

Volltextzugriff (PDF)

Randomised phase II study comparing topotecan/carboplatin administration for 5 versus 3 days in the treatment of extensive-stage small-cell lung cancer

Annals of oncology, 2007-01, Vol.18 (1), p.104-109

2007

Volltextzugriff (PDF)

Ifosfamide, carboplatin and etoposide combined with 41.8 °C whole body hyperthermia for malignant pleural mesothelioma

Lung cancer (Amsterdam, Netherlands), 2003-03, Vol.39 (3), p.339-345

2003

Volltextzugriff (PDF)

Phase II study of paclitaxel and cisplatin in patients with non-small cell lung cancer

Seminars in oncology, 1996-12, Vol.23 (6), p.47-50

1996

Volltextzugriff (PDF)

A phase II study of pirarubicin in malignant pleural mesothelioma

Cancer, 1990-08, Vol.66 (4), p.651-654

1990

Volltextzugriff (PDF)

Paclitaxel, carboplatin, and oral etoposide: a phase II trial in limited-stage small cell lung cancer

Seminars in oncology, 1997-08, Vol.24 (4 Suppl 12), p.S12

1997

Volltextzugriff (PDF)

Paclitaxel and cisplatin in patients with non-small cell lung cancer: results of a phase II trial

Seminars in oncology, 1996-10, Vol.23 (5 Suppl 12), p.7

1996

Volltextzugriff (PDF)

Clinical prognostic factors in advanced non-small cell lung cancer (NSCLC): Cox regression analysis based on 789 patients treated in three consecutive randomized trials

Journal of clinical oncology, 2007-06, Vol.25 (18_suppl), p.7648-7648

2007

Volltextzugriff (PDF)

Sequencing of single-agent (SA) docetaxel (T) and gemcitabine (G) therapy for patients (pts) with advanced non-small cell lung cancer (NSCLC): Results of three consecutive randomized trials

Journal of clinical oncology, 2006-06, Vol.24 (18_suppl), p.7035-7035

2006

Volltextzugriff (PDF)

Phase III trial with and without lonidamine in non-small cell lung cancer

Seminars in oncology, 1991-04, Vol.18 (2), p.42-48

1991

Volltextzugriff (PDF)

A phase II/III randomized study in advanced non-small cell lung cancer (NSCLC) with first line combination versus sequential gemcitabine and docetaxel: Interim study results

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.7095-7095

2004

Volltextzugriff (PDF)

A phase II/III randomized study in advanced non-small cell lung cancer (NSCLC) with first line combination versus sequential gemcitabine and docetaxel: Interim study results

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.7095-7095

2004

Volltextzugriff (PDF)

A phase II/III randomized study in advanced non-small cell lung cancer (NSCLC) with first line combination versus sequential gemcitabine (G) and docetaxel (D): Update on quality of life (QoL), toxicity, and costs

Journal of clinical oncology, 2005-06, Vol.23 (16_suppl), p.7057-7057

2005

Volltextzugriff (PDF)

O-102 Gemcitabine and docetaxel as concomitant or sequential first-linetherapy of advanced non-small cell lung cancer: Updated results of a randomized study

Lung cancer (Amsterdam, Netherlands), 2005-07, Vol.49, p.S36-S36

2005

Volltextzugriff (PDF)

Single-agent pemetrexed or sequentially administered pemetrexed/gemcitabine as first-line chemotherapy for advanced non-small cell lung cancer (NSCLC) in elderly patients or patients ineligible for platinum-based chemotherapy: Preliminary results of a phase II randomized trial

Journal of clinical oncology, 2005-06, Vol.23 (16_suppl), p.7156-7156

2005

Volltextzugriff (PDF)

Long-term survival in SCLC after treatment with paclitaxel, carboplatin and etoposide—A phase II study

Lung cancer (Amsterdam, Netherlands), 2003, Vol.39 (1), p.63-69

2003

Volltextzugriff (PDF)

A randomized trial with mitomycin-C/ifosfamide versus mitomycin-C/vindesine versus cisplatin/etoposide in advanced non-small-cell lung cancer

American journal of clinical oncology, 1991-10, Vol.14 (5), p.405-411

1991

Volltextzugriff (PDF)

Value of serum and effusion fluid CEA levels for distinguishing between diffuse malignant mesothelioma and carcinomatous pleural metastases

Lung, 1994-05, Vol.172 (3), p.183-184

1994

Volltextzugriff (PDF)

P-488 Phase II randomized trial of single-agent pemetrexed orsequentially administered pemetrexed/gemcitabine as front-line chemotherapy for the treatment of advanced non-small cell lung cancer (NSCLC) in elderly patients or patients ineligible for platinum-based chemotherapy

Lung cancer (Amsterdam, Netherlands), 2005-07, Vol.49, p.S245-S245

2005

Volltextzugriff (PDF)

Ifosfamide, carboplatin and etoposide combined with 41.8 degrees C whole body hyperthermia for malignant pleural mesothelioma

Lung cancer (Amsterdam, Netherlands), 2003-03, Vol.39 (3), p.339

2003

Volltextzugriff (PDF)

Therapy of malignant pleural mesothelioma

Medizinische Klinik (München. 1983), 1991-05, Vol.86 (5), p.259-262

1991

Volltextzugriff (PDF)

P-567 Topotecan/carboplatin 5 days versus topotecan/carboplatin 3 days in patients with metastasic small cell lung cancer

Lung cancer (Amsterdam, Netherlands), 2003-08, Vol.41, p.S234-S235

2003

Volltextzugriff (PDF)

ICE-Chemotherapie in Kombination mit Ganzkörperhyperthermie bei fortgeschrittenem malignen Pleuramesotheliom

Pneumologie, 2004

2004

Volltextzugriff (PDF)

1 – 25 von 222

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(190)
Mit Volltextzugriff
(140)

Publikationsform

Sprache

Englisch
(154)
Deutsch
(69)

Erscheinungsjahr

n.n

Thema

Science & Technology
(77)
Life Sciences & Biomedicine
(57)
Humans
(52)
Female
(39)
Male
(37)
Middle Aged
(33)
Adult
(26)
Aged
(26)
Biological And Medical Sciences
(24)
Physical Sciences
(20)
Medical Sciences
(18)
Animals
(17)
Physics
(17)
Lung Neoplasms - Drug Therapy
(16)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(14)
Pharmacology. Drug Treatments
(14)
Oncology
(13)
Exact Sciences And Technology
(12)
Physics, Condensed Matter
(11)
Carcinoma, Small Cell - Drug Therapy
(10)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Re: Detection of Individual Prostate Cancer Foci via Multiparametric Magnetic Resonance Imaging

Radical inguinal orchidectomy: the gold standard for initial management of testicular cancer

Effects of granulocyte-macrophage colony-stimulating factor and dose intensification of V-ICE chemotherapy in small-cell lung cancer: a prospective randomized study of 300 patients

Randomised phase II study comparing topotecan/carboplatin administration for 5 versus 3 days in the treatment of extensive-stage small-cell lung cancer

Ifosfamide, carboplatin and etoposide combined with 41.8 °C whole body hyperthermia for malignant pleural mesothelioma

Phase II study of paclitaxel and cisplatin in patients with non-small cell lung cancer

A phase II study of pirarubicin in malignant pleural mesothelioma

Paclitaxel, carboplatin, and oral etoposide: a phase II trial in limited-stage small cell lung cancer

Paclitaxel and cisplatin in patients with non-small cell lung cancer: results of a phase II trial

Clinical prognostic factors in advanced non-small cell lung cancer (NSCLC): Cox regression analysis based on 789 patients treated in three consecutive randomized trials

Sequencing of single-agent (SA) docetaxel (T) and gemcitabine (G) therapy for patients (pts) with advanced non-small cell lung cancer (NSCLC): Results of three consecutive randomized trials

Phase III trial with and without lonidamine in non-small cell lung cancer

A phase II/III randomized study in advanced non-small cell lung cancer (NSCLC) with first line combination versus sequential gemcitabine and docetaxel: Interim study results

A phase II/III randomized study in advanced non-small cell lung cancer (NSCLC) with first line combination versus sequential gemcitabine and docetaxel: Interim study results

A phase II/III randomized study in advanced non-small cell lung cancer (NSCLC) with first line combination versus sequential gemcitabine (G) and docetaxel (D): Update on quality of life (QoL), toxicity, and costs

O-102 Gemcitabine and docetaxel as concomitant or sequential first-linetherapy of advanced non-small cell lung cancer: Updated results of a randomized study

Single-agent pemetrexed or sequentially administered pemetrexed/gemcitabine as first-line chemotherapy for advanced non-small cell lung cancer (NSCLC) in elderly patients or patients ineligible for platinum-based chemotherapy: Preliminary results of a phase II randomized trial

Long-term survival in SCLC after treatment with paclitaxel, carboplatin and etoposide—A phase II study

A randomized trial with mitomycin-C/ifosfamide versus mitomycin-C/vindesine versus cisplatin/etoposide in advanced non-small-cell lung cancer

Value of serum and effusion fluid CEA levels for distinguishing between diffuse malignant mesothelioma and carcinomatous pleural metastases

P-488 Phase II randomized trial of single-agent pemetrexed orsequentially administered pemetrexed/gemcitabine as front-line chemotherapy for the treatment of advanced non-small cell lung cancer (NSCLC) in elderly patients or patients ineligible for platinum-based chemotherapy

Ifosfamide, carboplatin and etoposide combined with 41.8 degrees C whole body hyperthermia for malignant pleural mesothelioma

Therapy of malignant pleural mesothelioma

P-567 Topotecan/carboplatin 5 days versus topotecan/carboplatin 3 days in patients with metastasic small cell lung cancer

ICE-Chemotherapie in Kombination mit Ganzkörperhyperthermie bei fortgeschrittenem malignen Pleuramesotheliom

Suchergebnisse filtern